Year: 2016
Type: article
Abstract: A longer duration of lenalidomide maintenance appears to improve survival outcomes. Patients who will benefit still cannot be distinguished from those who will not. See also pages 3831‐7.
Source: Cancer
DOI: 10.1002/cncr.30363
Author: Saad Z. Usmani
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2527700528
